340 related articles for article (PubMed ID: 28446690)
1. Antimalarial efficacy of MMV390048, an inhibitor of
Paquet T; Le Manach C; Cabrera DG; Younis Y; Henrich PP; Abraham TS; Lee MCS; Basak R; Ghidelli-Disse S; Lafuente-Monasterio MJ; Bantscheff M; Ruecker A; Blagborough AM; Zakutansky SE; Zeeman AM; White KL; Shackleford DM; Mannila J; Morizzi J; Scheurer C; Angulo-Barturen I; Martínez MS; Ferrer S; Sanz LM; Gamo FJ; Reader J; Botha M; Dechering KJ; Sauerwein RW; Tungtaeng A; Vanachayangkul P; Lim CS; Burrows J; Witty MJ; Marsh KC; Bodenreider C; Rochford R; Solapure SM; Jiménez-Díaz MB; Wittlin S; Charman SA; Donini C; Campo B; Birkholtz LM; Hanson KK; Drewes G; Kocken CHM; Delves MJ; Leroy D; Fidock DA; Waterson D; Street LJ; Chibale K
Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446690
[TBL] [Abstract][Full Text] [Related]
2. Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel
Sinxadi P; Donini C; Johnstone H; Langdon G; Wiesner L; Allen E; Duparc S; Chalon S; McCarthy JS; Lorch U; Chibale K; Möhrle J; Barnes KI
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932368
[TBL] [Abstract][Full Text] [Related]
3. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048.
McCarthy JS; Donini C; Chalon S; Woodford J; Marquart L; Collins KA; Rozenberg FD; Fidock DA; Cherkaoui-Rbati MH; Gobeau N; Möhrle JJ
Clin Infect Dis; 2020 Dec; 71(10):e657-e664. PubMed ID: 32239164
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the Antimalarial MMV390048 against
Ji S; Galon EM; Rizk MA; Yi Y; Zafar I; Li H; Ma Z; Iguchi A; Asada M; Liu M; Xuan X
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0057422. PubMed ID: 35924942
[TBL] [Abstract][Full Text] [Related]
5. Heterologous Expression, Purification, and Functional Analysis of the
Sternberg AR; Roepe PD
Biochemistry; 2020 Jul; 59(27):2494-2506. PubMed ID: 32543181
[TBL] [Abstract][Full Text] [Related]
6. Targeting Plasmodium PI(4)K to eliminate malaria.
McNamara CW; Lee MC; Lim CS; Lim SH; Roland J; Simon O; Yeung BK; Chatterjee AK; McCormack SL; Manary MJ; Zeeman AM; Dechering KJ; Kumar TS; Henrich PP; Gagaring K; Ibanez M; Kato N; Kuhen KL; Fischli C; Nagle A; Rottmann M; Plouffe DM; Bursulaya B; Meister S; Rameh L; Trappe J; Haasen D; Timmerman M; Sauerwein RW; Suwanarusk R; Russell B; Renia L; Nosten F; Tully DC; Kocken CH; Glynne RJ; Bodenreider C; Fidock DA; Diagana TT; Winzeler EA
Nature; 2013 Dec; 504(7479):248-253. PubMed ID: 24284631
[TBL] [Abstract][Full Text] [Related]
7. Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria.
Kandepedu N; Gonzàlez Cabrera D; Eedubilli S; Taylor D; Brunschwig C; Gibhard L; Njoroge M; Lawrence N; Paquet T; Eyermann CJ; Spangenberg T; Basarab GS; Street LJ; Chibale K
J Med Chem; 2018 Jul; 61(13):5692-5703. PubMed ID: 29889526
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
[TBL] [Abstract][Full Text] [Related]
9. Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria.
Gibhard L; Njoroge M; Paquet T; Brunschwig C; Taylor D; Lawrence N; Abay E; Wittlin S; Wiesner L; Street LJ; Chibale K; Basarab GS
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249687
[TBL] [Abstract][Full Text] [Related]
10. Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.
Fracisco S; Teja-isavadharm P; Gettayacamin M; Berman J; Li Q; Melendez V; Saunders D; Xie L; Ohrt C
Malar J; 2014 Oct; 13():409. PubMed ID: 25326032
[TBL] [Abstract][Full Text] [Related]
11. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
Dominguez JN; Leon C; Rodrigues J; Gamboa de Dominguez N; Gut J; Rosenthal PJ
Eur J Med Chem; 2009 Apr; 44(4):1457-62. PubMed ID: 19036479
[TBL] [Abstract][Full Text] [Related]
13. SnapShot: Antimalarial Drugs.
Luth MR; Winzeler EA
Cell; 2020 Oct; 183(2):554-554.e1. PubMed ID: 33064992
[TBL] [Abstract][Full Text] [Related]
14. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
[TBL] [Abstract][Full Text] [Related]
15. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
16. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
[TBL] [Abstract][Full Text] [Related]
17. Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity.
Ashton TD; Ngo A; Favuzza P; Bullen HE; Gancheva MR; Romeo O; Parkyn Schneider M; Nguyen N; Steel RWJ; Duffy S; Lowes KN; Sabroux HJ; Avery VM; Boddey JA; Wilson DW; Cowman AF; Gilson PR; Sleebs BE
Bioorg Chem; 2021 Dec; 117():105359. PubMed ID: 34689083
[TBL] [Abstract][Full Text] [Related]
18. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
[TBL] [Abstract][Full Text] [Related]
19. Hepatic spheroids used as an in vitro model to study malaria relapse.
Chua ACY; Ananthanarayanan A; Ong JJY; Wong JY; Yip A; Singh NH; Qu Y; Dembele L; McMillian M; Ubalee R; Davidson S; Tungtaeng A; Imerbsin R; Gupta K; Andolina C; Lee F; S-W Tan K; Nosten F; Russell B; Lange A; Diagana TT; Rénia L; Yeung BKS; Yu H; Bifani P
Biomaterials; 2019 Sep; 216():119221. PubMed ID: 31195301
[TBL] [Abstract][Full Text] [Related]
20. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
